- Level 3 Communications Incorporated (LVLT) to acquire Global Crossing Ltd (GLBC).
- Flowers Foods Inc (FLO) to acquire Tasty Baking Co (TSTY).
- Endo Pharmaceuticals Holding Inc (ENDP) to acquire American Medical Systems Holdings Inc (AMMD).
- Silgan Holdings Inc (SLGN) to acquire Graham Packaging Co Inc (GRM).
- AML Communications Inc (AMLJ) signs merger agreement with Microsemi Corp (MSCC) and recommends voting against Anaren (ANEN) deal.
- William Hill PLC to acquire American Wagering Inc (BETM).
- Merck & Co Inc (MRK) to acquire Inspire Pharmaceuticals Inc (ISPH).
- Chesapeake Energy Corp (CHK) to acquire Bronco Drilling Co Inc (BRNC).
- Verizon Communications Inc (VZ) completes acquisition of Terremark Worldwide Inc (TMRK).
- Forest Laboratories Inc (FRX) completes acquisition of Clinical Data Inc (CLDA).
- Chemung Financial Corp (CHMG) completes acquisition of Capital Bank & Trust Company (FOFC).
- Gammon Gold Incorporated (GRS) completes acquisition of Capital Gold Corp (CGC).
- Insiders complete acquisition of Tongjitang Chinese Medicines Co (TCM).
- AFCV Holdings completes acquisition of Answers Corp (ANSW).
- First Niagara Financial Group Inc (FNFG) completes acquisition of Newalliance Bancshares Inc (NAL).
- Magnum Hunter Resources Corp (MHR) completes acquisition of NGAS Resources Inc (NGAS).
- Ventas Inc (VTR) files S-4 in merger with Nationwide Health Properties Inc (NHP).
- Nara Bancorp Inc (NARA) files S-4 in merger with Center Financial Corp (CLFC).
- IBERIABANK Corp (IBKC) files S-4 in merger with Omni Bancshares Inc (OMBA).
- Kindred Healthcare Inc (KND) announces that the HSR waiting period has expired in planned merger with Rehabcare Group Inc (RHB).
- Quest Diagnostics Inc (DGX) announces that the HSR waiting period has expired in planned merger with Celera Corporation (CRA).
- Forest Laboratories Inc (FRX) completes tender offer for Clinical Data Inc (CLDA).
- North Penn Bancorp Inc (New) (NPBP) shareholders approve acquisition by Norwood Financial Corp (NWFL).
- Barron's: LBO Hunt: Who's Next?
No comments:
Post a Comment